This page contains a collection of resources for a handful of different topics. I eventually got tired of having to repeatedly track down links and code examples for people, so I’ve decided to centralize everything here.
Agonist
- GAZYVA (Obinutuzumab) — Cancer [CD20 ]
- NPLATE (Romiplostim) — Other [CD110 ]
- ORTHOCLONE OKT3 (Muromonab CD3) — Transplants [CD3 ]
Antagonist
- ACTEMRA (Tocilizumab) — AutoimmunityCancer [CD126(IL-6R) ]
- AMEVIVE (Alefacept) — Autoimmunity [CD2 ]
- AMJEVITA (Adalimumab atto) — Autoimmunity [TNFα ]
- ANTHIM (Obiltoxaximab) — Infection [Anthrax ]
- ARCALYST (Rilonacept) — Other [IL-1 ]
- AVASTIN (Bevacizumab) — Cancer [VEGF-A ]
- BAVENCIO (Avelumab) — Cancer [CD274(PD-L1) ]
- BENLYSTA (Belimumab) — Autoimmunity [CD257(BAFF) ]
- CIMZIA (Certolizumab pegol) — Autoimmunity [TNFα ]
- CINQUAIR (Reslizumab) — Autoimmunity [IL-5 ]
- COSENTYX (Secukinumab) — Autoimmunity [IL-17α ]
- CYLTEZO (Adalimumab adbm) — Autoimmunity [TNFα ]
- CYRAMZA (Ramucirumab) — Cancer [VEGFR2 ]
- DUPIXENT (Dupliumab) — Autoimmunity [IL-4Rα ]
- ENBREL (Etanercept) — Autoimmunity [TNFα ]
- ENTYVIO (Vedolizumab) — Autoimmunity [Integrin-α4β7 ]
- ERBITUX (Cetuximab) — Cancer [EGFR ]
- HERCEPTIN (Trastuzumab) — Cancer [CD340(HER2) ]
- HUMIRA (Adalimumab) — Autoimmunity [TNFα ]
- ILARIS (Canakinumab) — Other [IL-1b ]
- IMFINZI (Durvalumab) — Cancer [CD274(PD-L1) ]
- INFLECTRA (Infliximab dyyb) — Autoimmunity [TNFα ]
- IXIFI (Infliximab qbtx) — Autoimmunity [TNFα ]
- KADCYLA (Ado Trastuzumab emtansine) — Cancer [CD340(HER2) ]
- KEVZARA (Sarilumab) — Autoimmunity [CD126(IL-6R) ]
- KEYTRUDA (Pembrolizumab) — Cancer [CD279(PD-1) ]
- LARTRUVO (Olaratumab) — Cancer [PDGFRα ]
- LUCENTIS (Ranibizumab) — Other [VEGF-A ]
- MVASI (Bevacizumab awwb) — Cancer [VEGF-A ]
- NUCALA (Mepolizumab) — Autoimmunity [IL-5 ]
- NULOJIX (Belatacept) — Transplants [CD80 CD86]
- OGIVRI (Trastuzumab dkst) — Cancer [CD340(HER2) ]
- OPDIVO (Nivolumab) — Cancer [CD279(PD-1) ]
- ORENCIA (Abatacept) — Autoimmunity [CD80 CD86]
- PERJETA (Pertuzumab) — Cancer [CD340(HER2) ]
- PORTRAZZA (Necitumumab) — Cancer [EGFR ]
- PRALUENT (Alirocumab) — Other [PCSK9 ]
- PRAXBIND (Idarucizumab) — Other [Dabigatran ]
- PROLIA (Denosumab) — Other [CD254(RANKL) ]
- RAPTIVA (Efalizumab) — Autoimmunity [CD11a(LFA-1) ]
- RAXIBACUMAB (Raxibacumab) — Infection [Anthrax ]
- REMICADE (Infliximab) — Autoimmunity [TNFα ]
- RENFLEXIS (Infliximab abda) — Autoimmunity [TNFα ]
- REOPRO (Abciximab) — Other [CD41(Integrin-α2β) ]
- REPATHA (Evolocumab) — Other [PCSK9 ]
- SILIQ (Brodalumab) — Autoimmunity [IL-17R ]
- SIMPONI (Golimumab) — Autoimmunity [TNFα ]
- SIMPONI ARIA (Golimumab) — Autoimmunity [TNFα ]
- SOLIRIS (Eculizumab) — Other [C5 ]
- STELARA (Ustekinumab) — Autoimmunity [IL-12 IL-23]
- SYLVANT (Siltuximab) — Other [IL-6 ]
- SYNAGIS (Palivizumab) — Infection [Fprotein(RSV) ]
- TALTZ (Ixekizumab) — Autoimmunity [IL-17α ]
- TECENTRIQ (Atezolizumab) — Cancer [CD274(PD-L1) ]
- TREMFYA (Guselkumab) — Autoimmunity [IL-23α ]
- TYSABRI (Natalizumab) — Autoimmunity [Integrin-α4 ]
- VECTIBIX (Panitumumab) — Cancer [EGFR ]
- XGEVA (Denosumab) — Cancer [CD254(RANKL) ]
- XOLAIR (Omalizumab) — Autoimmunity [IgE-Fc ]
- YERVOY (Ipilimumab) — Cancer [CD152(CTLA-4) ]
- ZINPLAVA (Bezlotoxumab) — Infection [Toxin-B ]
ADC
- ADCETRIS (Brentuximab vedotin) — Cancer [CD30(TNFRSF8) ]
- BESPONSA (Inotuzumab ozogamicin) — Cancer [CD22 ]
- HEMLIBRA (Emicizumab kxwh) — Hemophilia [FactorIXa FactorX]
- KADCYLA (Ado Trastuzumab emtansine) — Cancer [CD340(HER2) ]
- MYLOTARG (Gemtuzumab ozogamicin) — Cancer [CD33 ]
- RITUXAN HYCELA (Rituximab hyaluronidase) — Cancer [CD20 ]
ADCC
- ACTEMRA (Tocilizumab) — AutoimmunityCancer [CD126(IL-6R) ]
- ARZERRA (Ofatumumab) — Cancer [CD20 ]
- CAMPATH (Alemtuzumab) — Autoimmunity [CD52 ]
- DARZALEX (Daratumumab) — Cancer [CD38 ]
- EMPLICITI (Elotuzumab) — Cancer [CD319(SLAMF7) ]
- FASENRA (Benralizumab) — Autoimmunity [IL-5Rα ]
- GAZYVA (Obinutuzumab) — Cancer [CD20 ]
- HEMLIBRA (Emicizumab kxwh) — Hemophilia [FactorIXa FactorX]
- LEMTRADA (Alemtuzumab) — Cancer [CD52 ]
- MYLOTARG (Gemtuzumab ozogamicin) — Cancer [CD33 ]
- OCREVUS (Ocrelizumab) — Autoimmunity [CD20 ]
- REMOVAB (Catumaxomab) — Cancer [EpCAM CD3]
- RITUXAN (Rituximab) — AutoimmunityCancer [CD20 ]
- RITUXAN HYCELA (Rituximab hyaluronidase) — Cancer [CD20 ]
- SIMULECT (Basiliximab) — Transplants [CD25(IL-2Rα) ]
- UNITUXIN (Dinutuximab) — Cancer [GD2 ]
- ZENPAX (Daclizumab) — Transplants [CD25(IL-2Rα) ]
- ZINBRYTA (Daclizumab) — Autoimmunity [CD25(IL-2Rα) ]
TDCC
Imaging
- CEA-SCAN (Arcitumomab) — Cancer [CD66(CEA) ]
- MYOSCINT (Imciromab) — Other [CardiacMyosin ]
- NEUTROSPEC (fanolesomab) — Other [CD15 ]
- PROSTASCINT (Capromab pendetide) — Cancer [PSMA ]
- VERLUMA (Nofetumomab merpentan) — Cancer [EpCAM CD20]
- ZEVALIN (Ibritumomab tiuxetan) — Cancer [CD20 ]